StemCell Institute News

StemCell Institute: Regarding matters related to dominant shareholders.

Jun 27 02:30 ET

StemCell Institute: Matters related to business plans and growth potential.

Jun 27 02:30 ET

StemCell Institute: Independent Company Executives Declaration

Jun 4 02:00 ET

StemCell Institute: Notice regarding the year-end dividend forecast for the 2nd quarter (dividend commemorating the 25th anniversary of establishment (first dividend)) for the fiscal year ending March 31, 2025

May 14 02:30 ET

StemCell Institute: Notice Concerning the Recording of Gains (Extraordinary Profit) from the Sale of Investment Securities

Apr 25 00:50 ET

StemCell Institute: Notice regarding executive officers, general personnel affairs, and organizational restructuring

Jan 21 22:30 ET

StemCell Institute: Notice regarding the selection of loan stocks for our shares

Jan 12 03:00 ET

StemCell Institute: Notice regarding the capital and business alliance between Stemcell Research Institute Co., Ltd. and Japan Medical Company Co., Ltd.

Aug 28, 2023 23:00 ET

StemCell Institute: Announcement of a classical concert with the aim of contributing to the SDGs

Aug 1, 2023 00:00 ET

StemCell Institute: Matters relating to controlling shareholders, etc.

Jun 30, 2023 02:30 ET

StemCell Institute: Progress based on plans to comply with listing maintenance standards

Jun 30, 2023 02:30 ET

StemCell Institute: Matters relating to business plans and growth potential

Jun 28, 2023 02:30 ET

StemCell Institute: Independent Officer Notification Form

Jun 8, 2023 02:00 ET

StemCell Institute: Conclusion of a researcher-led clinical research agreement on “development of treatment methods using autologous cord blood nucleated cells for autism spectrum disorder”

Jun 5, 2023 01:00 ET

StemCell Institute: Notice of commencement of production service for “umbilical cord derived stem cell culture supernatant”

May 23, 2023 02:30 ET

StemCell Institute: Notice Concerning the Appointment of Candidates for Directors, Auditors, and Alternate Auditors

May 16, 2023 02:00 ET

StemCell Institute: Notice regarding head office relocation

Apr 19, 2023 02:30 ET

StemCell Institute: Notice on Directors / Executive Directors and General personnel

Feb 20, 2023 21:00 ET

StemCell Institute: Notice on Business Cooperation with Baby Calendar Co., Ltd in the fields of pregnancy, childbirth and parenting

Jan 30, 2023 01:00 ET

StemCell Institute: Measures about the application of our company in the medical treatment of menstrual blood stem cell regeneration

Sep 12, 2022 23:00 ET